Patient P-03192
Therapy response
Stable
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
36%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S11
- Day 44 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 44.
Primary contributors, last 14 days
- GI instability+11
- Toxicity-7
- Inflammatory activity+5
- Nutritional resilience-5
What helped?
No interventions yet.
LIFE OS recommendation
Dosing / Timing Recommendation DT-01
53%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 80% showed improvement
- median effect visible after 5 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log6/10
stable · -0.0 vs previous 14 d
Stress level
Daily log5.2/10
stable · +0.0 vs previous 14 d
Pessimism score
Daily log4.3/10
worsening · +0.2 vs previous 14 d
Sleep quality
Wearable50.9/100
improving · +3.8 vs previous 14 d
Libido
Daily log5.1/10
stable · +0.0 vs previous 14 d
HRV
Wearable42.1 ms
improving · +2.7 vs previous 14 d
Toxicity
Blood12.5/100
stable · +0.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 58 from the failing basin, 30 from restoration.
Would help
Would not help
- AD-05 Adherence Supportonly 25% improved among 12 similar
- Keep lactose lowGI +3.7 next day on high-intake days · n 22
- Keep caffeine lowGI +3.2 next day on high-intake days · n 11
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-5.7supporter · 95%
- Lactose+3.7detractor · 86%
- Caffeine+3.2detractor · 85%
- Alcohol+1.3no signal · 36%
- Histamine load+1no signal · 22%
- Dietary fat load+0.3no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 3.7 · butyrate capacity 62/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 47 ms
- Sleep
- 7.9 h
- Steps
- 4,890
- Resting HR
- 62 bpm
Daily log: GI score 38, nutritional resilience 54, adherence 90.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-03178 | 48% | S11 | GI-04 | improved | 54 |
| P-03252 | 47% | S13 | SC-12 | improved | 68 |
| P-03057 | 44% | S14 | NP-02 | improved | 64 |
| P-03374 | 43% | S19 | ME-01 | improved | 55 |
| P-03255 | 40% | S01 | HY-01 | improved | 53 |
| P-03484 | 39% | S07 | DT-01 | improved | 49 |
| P-03144 | 38% | S16 | HY-01 | improved | 52 |
| P-03179 | 38% | S05 | GI-04 | improved | 52 |
| P-03204 | 38% | S16 | AD-05 | improved | 48 |
| P-03208 | 37% | S02 | BR-03 | improved | 57 |
| P-03328 | 37% | S15 | GI-04 | improved | 59 |
| P-03442 | 37% | S11 | DT-01 | improved | 51 |